SCHEMBL30640985

SCHEMBL30640985

CCc1ccnc(C#N)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.52
NOS1 P29475 1/20 0.52
NOS2 P35228 1/20 0.52
CYP2A6 P11509 1/20 0.42
LRRK2 Q5S007 1/20 0.40
MYC P01106 1/20 0.39
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
XDH P47989 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
CTSK P43235 3/20 0.35
CTSS P25774 1/20 0.35
PARP14 Q460N5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3302943 1.00 NOS3 (0.52) NOS3NOS1NOS2CYP2A6LRRK2
SCHEMBL2547947 0.85 CTSK (0.40) NOS3NOS1NOS2MYCCYP3A4
SCHEMBL6244474 0.81 LOXL2 (0.46) NOS3NOS1MYCCYP3A4XDH
SCHEMBL5509083 0.80 HSD17B10 (0.45) CYP3A4HPGD
SCHEMBL2642690 0.80 LOXL2 (0.52) MYCXDHABCG2
SCHEMBL454924 0.80 RECQL (0.52) MYCXDHABCG2PARP14GRM2
SCHEMBL451724 0.80 MYC (0.39) MYCXDHABCG2CTSKPARP14
SCHEMBL2642689 0.80 MYC (0.39) MYCXDHABCG2CTSKPARP14
SCHEMBL6466230 0.80 MYC (0.39) MYCXDHABCG2PARP14GRM2
SCHEMBL451725 0.80 MYC (0.39) MYCXDHABCG2PARP14GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117534670-A Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders 加拉帕戈斯股份有限公司 2024-02-09 CN disclosed
CN-111225916-B Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders 加拉帕戈斯股份有限公司 2023-11-03 CN disclosed